Search results
Showing 901 to 915 of 1560 results for do not do recommendations
Evidence-based recommendations on atezolizumab (Tecentriq) for previously treated locally advanced or metastatic urothelial carcinoma in adults.
Recommendation ID NG146/2 Question What interventions are effective and cost effective in supporting return to work after recurrent...
Recommendation ID NG135/4 Question How effective and cost effective are education-based alcohol interventions targeted at children and
Recommendation ID NG135/5 Question How effective are education-based alcohol prevention interventions (universal or targeted) for...
Recommendation ID NG135/3 Question How effective and cost effective are universal, education-based alcohol interventions for children and
Recommendation ID CG168/4 Question Truncal treatment with or without concurrent tributary treatment:- What is the clinical and cost...
Recommendation ID NG135/1 Question What components of alcohol education delivery contribute to its effectiveness for children and young
Evidence-based recommendations on selpercatinib (Retsevmo) for advanced thyroid cancer with RET alterations untreated with a targeted cancer drug in people 12 years and over.
Asfotase alfa for treating paediatric-onset hypophosphatasia (HST23)
Evidence-based recommendations on asfotase alfa (Strensiq) for treating paediatric-onset hypophosphatasia in babies, children, young people and adults.
Recommendation ID CG155/1 Question What are the long-term outcomes, both psychotic and nonpsychotic, for children and young people with
Evidence-based recommendations on trifluridine–tipiracil (Lonsurf) with bevacizumab (Avastin) for treating metastatic colorectal cancer after 2 systemic treatments in adults.
Recommendation ID IPG737/01 Question Evidence on the safety and efficacy of prostatic urethral temporary implant insertion for lower...
Recommendation ID IPG739/01 Question Evidence on the efficacy and safety of neurostimulation of lumbar muscles for refractory...
Recommendation ID NG64/3 Question Effectiveness and cost effectiveness of drug misuse prevention interventions for groups vulnerable to
Recommendation ID NG31/1 Question Recognising dying:- What can multiprofessional teams do to reduce the impact of...